Navigation Links
Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies

GORDONSVILLE, Va., June 24 /PRNewswire/ -- PBM Products, LLC, a leading infant formula company that supplies store-brand infant formulas to Walmart, Sam's Club, Target, Kroger, CVS, Walgreens, and other retailers, has partnered with the University of Virginia (U.Va.) to conduct clinical studies on infant nutrition. U.Va. has been collaborating with PBM during the past few years on studies regarding PBM's milk, soy, and specialty infant formulas that compete with expensive national brands, including Enfamil(R) LIPIL(R) and Similac(R) Advance(R) formulas.

"We know breastfeeding is best for babies," said V.P. Cynthia M. Barber, Ph.D., who directs regulatory, medical, and clinical affairs at PBM. "If parents choose to supplement breast milk with formula, our store-brand formulas are nutritionally equivalent to Enfamil(R) LIPIL(R) and Similac(R) Advance(R) formulas and have science and clinical support behind them just like the brand-name formulas do. We feel our clinical work with University of Virginia is strengthening the public perception of store-brand infant formulas, which are as nutritionally complete as the national brand formulas and comply with the same FDA guidelines."

According to James L. Sutphen, M.D., Ph.D., U.Va. Department of Pediatrics and lead researcher on studies involving PBM formulas, it is very common for formula-fed infants to be switched from one formula to another during the first year of life.

"It's important to remember that all infant formulas manufactured and sold in the United States are strictly regulated by the Food and Drug Administration and must be backed by comprehensive growth and development studies," said Dr. Sutphen. "Our work proves there is no physiological reason why you can't switch from one brand of infant formula to another that shares the same protein source, which means store brands are just as nutritionally sound as national-brand formulas."

Store-brand formulas typically save parents up to 50 percent versus national brand formulas for a potential savings of $600 a year. Visit a baby formula savings calculator online to learn more at .

About PBM

PBM is privately owned and based in Gordonsville, VA. PBM companies specialize in manufacturing, distributing, and marketing consumer food, nutritional, and pharmaceutical products. For more information, visit

Enfamil(R) LIPIL(R) are registered trademarks of Mead Johnson & Co. Similac(R) Advance(R) are registered trademarks of Abbott Laboratories. PBM store-brand formula is neither made by nor affiliated with Mead Johnson or Abbott Laboratories.

    Contact:   Joe Shields
               Director of Public Relations
               (800) 959-2066 ext. 1131

Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
2. Infant Blood May Provide Insights into Diseases Present at Birth
3. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
4. Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease
5. Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill
6. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
7. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
8. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
9. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
10. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
11. Pregnant Women Need Omega-3 to Boost Infant Development
Post Your Comments:
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... ... teleradiology services, has added Chris Hafey and Claude Hooton to its board of ... Society of North America (RSNA) 2015 Annual Meeting and continues to strategically transform ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 ... savings. , With possible savings of up to 20% off orders $80 or more to ... the website every few hours. , As a competitive e-commerce website for skin care and ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... American Dental Association meeting in Washington D.C. revolved around the fact that proper dental ... health. The talk stressed the link between periodontal disease (more commonly referred to as ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
Breaking Medicine News(10 mins):